Adjuvant Carboplatin for Early-Stage, Triple-Negative Breast Cancer: Taxane and Patient Selection
Journal of Clinical Oncology · 20.08.2026 · 44 (24) · 2356-2356
DOI: 10.1200/jco-26-00140 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of Clinical Oncology, erschienen am 20.08.2026. Verfasst von Risako Komata und 3 weiteren Autor:innen. Beteiligte Einrichtung: Risako Komata, MD; Kenju Ando, MD, PhD; Akihiko Shimomura, MD, PhD; and Chikako Shimizu, MD, PhD, Department of Breast and Medical Oncology, National…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 3 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Risako Komata, MD; Kenju Ando, MD, PhD; Akihiko Shimomura, MD, PhD; and Chikako Shimizu, MD, PhD, Department of Breast and Medical Oncology, National Center for Global Health and Medicine, Japan Institute for Health Sec…
ORCID-Profile: Kenju Ando, Akihiko Shimomura, Chikako Shimizu
Zitieren
APA
Komata, R., Ando, K., Shimomura, A., & Shimizu, C. (2026). Adjuvant Carboplatin for Early-Stage, Triple-Negative Breast Cancer: Taxane and Patient Selection. Journal of Clinical Oncology, 44(24), 2356-2356. https://doi.org/10.1200/jco-26-00140
Vancouver
Komata R, Ando K, Shimomura A, Shimizu C. Adjuvant Carboplatin for Early-Stage, Triple-Negative Breast Cancer: Taxane and Patient Selection. Journal of Clinical Oncology. 2026;44(24):2356-2356. doi:10.1200/jco-26-00140
BibTeX
@article{Komata2026,
author = {Komata, Risako and Ando, Kenju and Shimomura, Akihiko and Shimizu, Chikako},
title = {Adjuvant Carboplatin for Early-Stage, Triple-Negative Breast Cancer: Taxane and Patient Selection},
journal = {Journal of Clinical Oncology},
year = {2026},
volume = {44},
number = {24},
pages = {2356--2356},
doi = {10.1200/jco-26-00140}
}
EUVIMED